biological source
human liver (hepatocytes)
form
liquid
usage
sufficient for 1 96-well plate(s) (or 24-well plate)
packaging
vial of 4 mil. cells
manufacturer/tradename
LifeNet Health®
growth mode
adherent
description
≥70%, confluent monolayer on day 5
technique(s)
cell culture | mammalian: suitable
drug transporter assay: suitable
genotyping: suitable
application(s)
ADME/TOX
relevant disease(s)
non-alcoholic steatohepatitis (NASH); non-alcoholic/simple fatty liver (NAFL)
shipped in
liquid nitrogen
storage temp.
−196°C
General description
We provide high viability cryoplatable hepatocytes, sourced from LifeNet Health® that predictably represents in vivo conditions. Applications for primary hepatocytes include in vitro evaluation of metabolism, drug-drug interaction, drug transporter activity, and toxicity of drug candidates. There are many other applications that encompass cryoplatable hepatocytes.
Packaging
This product will be shipped in a liquid nitrogen dry shipper supplied from Cryoport. Please remember to ship the container back to Cryoport once you have removed the materials. Additional Cryoport shipping charges may apply.
Please see the Cryoport website for more details on the dry shipper.
Please see the Cryoport website for more details on the dry shipper.
Legal Information
LifeNet Health is a registered trademark of LifeNet Health
Application
See technical bulletins for detailed protocols.
Click here to get a complete list of currently available hepatocyte lots from LifeNet Health®.
Once the lot number(s) of interest are determined enter the lot number into the “Certificate of Analysis” request search engine at the bottom of the page to obtain a pdf copy of the CoA. Note, lot number CoA upload is only available on the product number detail page corresponding with the lot number.
Click here to get a complete list of currently available hepatocyte lots from LifeNet Health®.
Once the lot number(s) of interest are determined enter the lot number into the “Certificate of Analysis” request search engine at the bottom of the page to obtain a pdf copy of the CoA. Note, lot number CoA upload is only available on the product number detail page corresponding with the lot number.
Features and Benefits
These cryoplatable hepatocytes are sourced from LifeNet Health®. All cryoplatable hepatocytes have post-thaw viabilities over 80%. These lots are also characterized for Phase I CYP450 isoform and Phase II drug-metabolizing enzyme activity. Cryoplatable hepatocytes can be used for a variety of applications including metabolic stability, clearance, metabolite ID, metabolite profiling, species comparison studies, and uptake transporter studies.
Each lot is fully characterized for viability/stability, cell yield, attachment efficiency, optimal seeding density, monolayer confluency, Phase I and Phase II drug metabolizing enzyme activities and cyp induction. We have a wide selection of lots that can be used for a variety of applications, including, but not limited to:
Each lot is fully characterized for viability/stability, cell yield, attachment efficiency, optimal seeding density, monolayer confluency, Phase I and Phase II drug metabolizing enzyme activities and cyp induction. We have a wide selection of lots that can be used for a variety of applications, including, but not limited to:
- Drug metabolizing enzyme activity (stability, clearance, species, metabolite profiling and ID)
- Time-dependent metabolism (plated assay for low-clearance compounds)
- CYP450 Induction (mRNA and activity)
- Plated drug transporter assays (uptake and efflux)
- Toxicity assays
- High content analysis
- High content imaging
- 3D culture
存储类别
10 - Combustible liquids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
高风险级别生物产品--人源产品
此项目有
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持